A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss.
about
Megestrol acetate for treatment of anorexia-cachexia syndromeMegestrol acetate for treatment of anorexia-cachexia syndromeThalidomide in the treatment of cancer cachexia: a randomised placebo controlled trialCancer and systemic inflammation: treat the tumour and treat the hostHigh prevalence of adrenal suppression during acute illness in hospitalized patients receiving megestrol acetateCancer cachexia: impact, mechanisms and emerging treatmentsThe Systemic Effect of Burn Injury and Trauma on Muscle and Bone Mass and Composition.Clinical anticachexia treatments.A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), resistance training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients--ACCeRT study.Non-steroidal anti-inflammatory drugs for the treatment of cancer cachexia: a systematic review.Pancreatic cancer cachexia: a review of mechanisms and therapeutics.Cancer cachexia, mechanism and treatmentCancer cachexia update in head and neck cancer: Pathophysiology and treatment.Review article: anorexia and cachexia in gastrointestinal cancer.The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer.A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer.The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer.Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome.An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer.Overview of emerging pharmacotherapy in chronic heart failure.Role of C-reactive protein as a biomarker for renal cell carcinoma.Non-steroidal anti-inflammatory treatment in cancer cachexia: a systematic literature review.Current pharmacotherapy options for cancer anorexia and cachexia.A systematic review of health-related quality of life instruments in patients with cancer cachexia.Phase II drugs that are currently in development for the treatment of cachexia.Taltirelin alleviates fatigue-like behavior in mouse models of cancer-related fatigue.Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation.An Immune-Modulating Diet in Combination with Chemotherapy Prevents Cancer Cachexia by Attenuating Systemic Inflammation in Colon 26 Tumor-Bearing Mice.Nutrition, infection and stunting: the roles of deficiencies of individual nutrients and foods, and of inflammation, as determinants of reduced linear growth of children.Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: Effects on survival, metabolism, and function.Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma.A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly.
P2860
Q24198954-5F0D81A8-EAA0-43FB-87E4-A57AE4BF3C78Q24244142-2EB9A8B6-5DFB-4BBC-ACDE-A820F08F7F90Q24685678-D9D25052-431F-4ED3-9558-92F56A409860Q26858815-870C8724-16E5-4016-8409-EBE145E6AF55Q28306821-B5FBCA1A-01B9-4C69-8B56-96C4676A4383Q28384479-CA1E9788-A8B0-4350-96B1-EC524F84971EQ30760745-C4C8EFDF-8597-4556-B93F-9627663B6837Q33994400-FC4EF639-000D-4736-AA3C-5AE19F39D0D5Q34082057-B7A5ADC8-2779-4DD0-9494-DE79D0D06996Q34636946-DBA4E053-4C5F-45FF-A56D-6C5ED8DBD24EQ34660312-124A3D65-CAC7-4307-9351-E8BAA79A259EQ34669440-BAF57B92-BF36-48C0-9711-EFAF19BF4111Q35122201-41D0F5F2-F978-4A26-A161-9CBAAA4706B2Q36266402-7F0A87A7-4F65-4BE8-9C25-95F7AA0F2811Q36614384-1021BA4D-0C51-47AF-AEC1-2CA000C6D82FQ36615878-8B7AABFF-C47E-4CC1-B7B0-77BACEB66AA7Q36696573-FFCD745F-0078-4441-8A1E-35DFB57D6753Q37103603-B6B735EF-76E3-48AB-9218-C1AE0B03C449Q37152934-C48C1A62-5472-4510-92D8-7C1A2224510EQ37552943-D9903FF0-73B0-4B1B-9C4E-B9B8AD4BFF79Q37812611-F4E3BC54-202A-428B-BEFA-C1D02DE800ECQ38047351-EC7D2164-1CFF-4ED8-A500-1DFA8C7DB129Q38052613-0E1B080E-4624-43D3-8AED-E736D1D77B72Q38116773-355F4367-C3BB-460B-81B0-460A3FFD92ACQ38233278-61DB828C-AB46-46BD-B38E-2899A051517EQ38673331-D6EDE239-5999-4381-9A29-C69F306D90BAQ38802465-2A77BA54-1A0C-44C7-9AB1-F88F15B329E1Q38857963-A6D11256-B859-4700-90E3-E346FFF8BA58Q40362252-6DAB8E2E-2346-4F5A-881C-2AF496604699Q45102906-763B550F-E406-4798-8C2A-84CFAC2BC7E1Q48351838-CD21D55D-59F7-422D-BB04-8E0FDE37B883Q49385576-13D6872D-60F0-4942-A068-4A7540F9D651
P2860
A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A prospective randomized study ...... cer patients with weight loss.
@ast
A prospective randomized study ...... cer patients with weight loss.
@en
A prospective randomized study ...... cer patients with weight loss.
@nl
type
label
A prospective randomized study ...... cer patients with weight loss.
@ast
A prospective randomized study ...... cer patients with weight loss.
@en
A prospective randomized study ...... cer patients with weight loss.
@nl
prefLabel
A prospective randomized study ...... cer patients with weight loss.
@ast
A prospective randomized study ...... cer patients with weight loss.
@en
A prospective randomized study ...... cer patients with weight loss.
@nl
P2093
P2860
P356
P1476
A prospective randomized study ...... cer patients with weight loss.
@en
P2093
McArdle CS
McMillan DC
O'Gorman P
Wigmore SJ
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690077
P407
P577
1999-02-01T00:00:00Z
P5875
P6179
1020423405